Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, ...
LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
"My dog has a tumor that has just popped up on her bottom jaw, and it's getting rather big rather fast. It's kind of hard and feels like a muscle. Do you think ivermectin might help? She is only 5 or ...
Companion animals often develop cancers similar to those found in humas. Dogs, in particular, have a vital role to play in the investigation of new cancer therapies. Increased funding and better ...
U.S. Department of Agriculture Center for Veterinary Biologics approves ECI®, a first-in-class adoptive cell therapy for the treatment of bone cancer in dogs ECI® is now available at 100 authorized ...
OS Animal Health may soon stand on its own. A subsidiary of OS Therapeutics—a company known for Listeria -based oncology ...
Two canine osteosarcoma patients who underwent amputations are shown in 2023, when their care team and owners celebrated their final chemo treatments by ringing a bell and giving both dogs lots of ...
The Queen’s Veterinary School Hospital (QVSH) at the University of Cambridge has joined forces with the Wellcome Sanger Institute to conduct research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback